October 07, 2026 06:21 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
RBI shocks borrowers with first repo rate hike since 2023; rates raised to 5.50% | ‘Completely false’: Virat Kohli reacts to ₹5 crore claim over Premanand Maharaj visit | We’re watching it very closely: US urges Russia to share more information on plague situation | This isn’t about schools: Trump blames ‘mass migration’ and Islam for violent protests across France | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘Vote thief’ Gyanesh Kumar: Rahul Gandhi climbs barricade, waves Tricolour during explosive INDIA bloc protest | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘He should not have been flying’: JD Vance on Flydubai co-pilot | Israel was ready to shoot down Flydubai jet if it kept flying towards Tel Aviv: Reports | 'If law wasn't followed, we can undo it': Supreme Court's big warning on SIR process amid Gyanesh Kumar row
COVID19 Vaccine

US to possibly supply COVID-19 vaccine to other countries: Prez Donald Trump

| @indiablooms | Jul 29, 2020, at 05:52 pm

Washington/UNI:  US President Donald Trump during a press briefing said the United States may provide a vaccine for the novel coronavirus to other countries when it is ready.

"When we have that vaccine it will be discharged and taken care of," Trump told reporters on Tuesday. "It will be a very rapid process all over the country and perhaps we'll be supplying a lot of the vaccine to other parts of the world like we do with ventilators and other things that we all of a sudden have become very good at making."

The Trump administration aims to have a vaccine available by the end of the year or early 2021, says a Sputnik news report.

On Monday, the National Institutes of Health (NIH) said that US scientists have begun the phase three trial of the potential vaccine developed by the biotechnology company Moderna.

The NIH plans to conduct the trial at multiple US clinical research sites with participation of approximately 30,000 adult volunteers who are not infected with the novel coronavirus.

The United States has reported more than 4.3 million cases and more than 149,000 virus-related deaths as of Tuesday afternoon, according to data compiled by the Johns Hopkins University. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.